Malaysia Radiotherapy Market Report 2022 to 2030

Malaysia Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Malaysia Radiotherapy Market will reach a value of $xx Mn from $11 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Malaysia is dominated by a few domestic players such as Innopharmax Technologies, Hicom-Teck, and VHMED. The radiotherapy market in Malaysia is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Malaysia Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10MYPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Malaysia AUTHOR: Dr. Vishwa Modhia

Buy Now

Malaysia Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Malaysia Radiotherapy Market will reach a value of $xx Mn from $11 Mn in 2022, growing at a CAGR of xx% during 2022-30.

Malaysia is a Southeast Asian federation of 13 states and three federal areas. It is a developing country with an upper-middle income. Cancer is one of Malaysia's worst diseases, killing 6,268 people in 2016. Cancer is not only terrible but also costly. In Malaysia, cancer incidence has increased in recent years, with the National Cancer Registry projecting a 3.4 % annual increase between 2007 and 2016. This has resulted in a rise in the demand for oncology medications.

Malaysia's government has been investing in healthcare and working to improve access to cancer treatment. Malaysia's government devoted 4.1% of its GDP to healthcare in 2020.

Malaysia Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

According to the Ministry of Health (MOH), 19,000 people were diagnosed with cancer 100,000 in 2014, with women accounting for more than half of those affected. Malaysians have a high per capita income, which means they have more purchasing power in the pharmaceutical and healthcare industries. These aspects could boost Malaysia's, Radiotherapy Market.

Market restrains.

Cancer patients have a disproportionately high mortality rate, notwithstanding Malaysia's pride in being a fast-growing nation with advanced health facilities. Malaysia's medical inflation rate was 11.5 % in 2016, with a predicted rate of 12.6 % in 2017. According to the 2013 Protection Gap in Malaysia report by the Life Insurance Association of Malaysia (LIAM), four to five out of every 10 Malaysians do not have life insurance. Radiation therapy costs between $750 to $3500 on average in Malaysia. These factors may deter new entrants into the Malaysia Radiotherapy Market.

Competitive Landscape

Key Players

VHMED- VHMED is a Malaysian company that provides a range of medical equipment, including radiotherapy equipment. The company offers a range of products, including linear accelerators, brachytherapy systems, and radiation protection solutions
Millennium Medical Solutions- Millennium Medical Solutions is a Malaysian company that provides a range of medical equipment, including radiotherapy equipment. The company has a presence in Malaysia and provides equipment to several healthcare facilities
Elekta - Elekta is a global company that provides advanced radiation therapy equipment and software solutions. In Malaysia, the company has a strong presence and offers a range of products, including linear accelerators, brachytherapy systems, and treatment planning software
Hicom-Teck See Manufacturing Malaysia - Hicom-Teck See Manufacturing Malaysia is a Malaysian company that specializes in precision manufacturing for various industries, including medical equipment. The company produces radiation therapy systems such as linear accelerators and brachytherapy equipment
ADAC Holdings - ADAC Holdings is a Malaysian company that designs, develops, and manufactures a range of medical equipment, including radiation therapy systems such as linear accelerators and treatment planning software
Innopharmax Technologies - Innopharmax Technologies is a Malaysian company that develops and produces medical devices, including radiation therapy systems such as linear accelerators and brachytherapy equipment

Notable Recent Deals

September 2022: IHH Healthcare Bhd signed a Memorandum of Understanding (MOU) with the Ministry of Health (MOH) through its wholly owned subsidiary Pantai Medical Centre Sdn Bhd to expand cancer care and treatment in Malaysia through its network of Pantai Hospitals, Gleneagles Hospitals, and Prince Court Medical Centre (PCMC). According to the agreement, IHH Healthcare Malaysia would fully fund radiotherapy and radiosurgery for 500 cancer patients receiving treatment at government facilities.

Healthcare Policies and Reimbursement Scenarios

In Malaysia, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Health (MOH) and the Ministry of Finance. The MOH is responsible for regulating the use of radiation in Malaysia, including the use of radiotherapy. The Malaysian Oncological Society (MOS) is the main professional organization for radiation oncologists in Malaysia and works closely with the MOH to develop guidelines and standards of practice for radiotherapy. The Ministry of Finance is responsible for reimbursing the cost of radiotherapy for eligible patients under the national health insurance program, which is known as the MySalam scheme.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.